SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
28-Mar-24 4:32 PM View: | Pyxis Oncology, Inc. (PYXS) | 26-Mar-24 | Grant | 38,741 | -- | -- | 67% 58.06K to 96.81K | |
28-Mar-23 4:43 PM View: | Pyxis Oncology, Inc. (PYXS) | 24-Mar-23 | Grant | 58,064 | -- | -- | 100% 0 to 58.06K | |
10-Sep-20 4:56 PM View: | Black Diamond Therapeutics,... (BDTX) | 08-Sep-20 | Grant | 10,000 | -- | -- | 100% 0 to 10.0K | |
05-Mar-18 6:59 PM View: | Cytomx Therapeutics, Inc. (CTMX) | 02-Mar-18 | Option Exercise | 16,160 | $6.61 | $106,894.00 | 53% 30.23K to 46.39K | |
05-Mar-18 6:59 PM View: | Cytomx Therapeutics, Inc. (CTMX) | 02-Mar-18 | Market Option Sale (Planned) | 16,160 | $30.00 | $484,800.00 | (35%) 46.39K to 30.23K | 74% |
02-Mar-18 11:55 AM View: | Cytomx Therapeutics, Inc. (CTMX) | 28-Feb-18 | Option Exercise | 23,840 | $6.61 | $157,694.00 | 79% 30.23K to 54.07K | |
02-Mar-18 11:55 AM View: | Cytomx Therapeutics, Inc. (CTMX) | 28-Feb-18 | Market Option Sale (Planned) | 23,840 | $30.00 | $715,200.00 | (44%) 54.07K to 30.23K | 74% |
19-Dec-17 12:23 PM View: | Cytomx Therapeutics, Inc. (CTMX) | 15-Dec-17 | Option Exercise | 15,117 | $6.61 | $99,994.40 | 100% 15.12K to 30.23K | |
29-Dec-16 3:52 PM View: | Cytomx Therapeutics, Inc. (CTMX) | 28-Dec-16 | Option Exercise | 15,117 | $6.61 | $99,994.40 | 100% 0 to 15.12K |